Insights

Innovation gives good reason for optimism

September 9, 2020
With most of us beginning to turn our thoughts back to running our businesses against the backdrop of a COVID-stricken economy, Dr Mark Tock points out that recessions create both...

Lockdown blues: insights from an inheritor

September 9, 2020
Reviewing lockdown life and attempts at emergence into a limited ‘new normal’ with no previous experience of what ‘normal’ career entry should look like, Amy Grace offers a first-hand perspective...

A researchers guide to lockdown

September 8, 2020
We may all be stuck at home but there is still science to be done! Dr Matthew Partridge explores the options while taking his own advice…

Jurassic Park style GM experiment flies under the radar

September 1, 2020
An Oxfordshire based company is at the centre of planned controversial use of GM modified mosquitoes in Florida to combat diseases mosquito-related diseases. Dermot Martin looks into the facts of...

How to use serum viscosity to understand COVID-19 patient risk

September 1, 2020
2020 has been a strange year all round. An unknown virus, probably in a bat colony in central China mutated to allow it to infect humans too. Within 3 months...

Bringing innate immunity centre stage in COVID-19 combat

August 17, 2020
A recent Canadian paper [1] has acknowledged that the innate immune system could have a direct effect on the body’s ability to respond to COVID-19, and we must continue to...

Can efficiency and sustainability coexist?

August 17, 2020
Allison Paradise, CEO of My Green lab, a non-profit organization and Marc Boreham vice president and general manager of Agilent's Laboratory Enterprise Solutions Division share their views on the interplay...

Medical cannabis growth could offer boom for lab industry

August 12, 2020
Further easing of import restrictions by the Government will provide faster access to patients prescribed cannabis-based medicines — and is the removal of yet another barrier in a market expected...

COVID-19 testing will be standard for clinical trials

August 7, 2020
Clinical trial specialist, Bärbel Wilke expects corona testing for both virus and antibody detection to become standard for the recruitment and continued participation of patients in clinical trials. Catherine Featherston...

How COVID-19 kills: a tale of two conditions

August 7, 2020
Steve Walton, explains why he believes the majority of patients that die after being infected with SARS CoV-2 virus infection do not die from respiratory failure, but because of a...

Pin It on Pinterest